Growth Metrics

SELLAS Life Sciences (SLS) Other Operating Expenses (2020 - 2023)

Historic Other Operating Expenses for SELLAS Life Sciences (SLS) over the last 4 years, with Q1 2023 value amounting to $184000.0.

  • SELLAS Life Sciences' Other Operating Expenses rose 214444.44% to $184000.0 in Q1 2023 from the same period last year, while for Dec 2023 it was $184000.0, marking a year-over-year decrease of 4320.99%. This contributed to the annual value of $10.1 million for FY2022, which is 7118.64% up from last year.
  • SELLAS Life Sciences' Other Operating Expenses amounted to $184000.0 in Q1 2023, which was up 214444.44% from $124000.0 recorded in Q3 2022.
  • Over the past 5 years, SELLAS Life Sciences' Other Operating Expenses peaked at $5.7 million during Q4 2021, and registered a low of -$160000.0 during Q2 2021.
  • For the 4-year period, SELLAS Life Sciences' Other Operating Expenses averaged around $505818.2, with its median value being -$9000.0 (2022).
  • In the last 5 years, SELLAS Life Sciences' Other Operating Expenses crashed by 66842.11% in 2021 and then skyrocketed by 214444.44% in 2023.
  • Over the past 4 years, SELLAS Life Sciences' Other Operating Expenses (Quarter) stood at $19000.0 in 2020, then soared by 29900.0% to $5.7 million in 2021, then plummeted by 97.82% to $124000.0 in 2022, then surged by 48.39% to $184000.0 in 2023.
  • Its Other Operating Expenses was $184000.0 in Q1 2023, compared to $124000.0 in Q3 2022 and $209000.0 in Q2 2022.